Loading clinical trials...

Semi-permanent Acupuncture Effect on Cervical Ripening | Clinical Trials | Clareo Health

TERMINATEDNA

Semi-permanent Acupuncture Effect on Cervical Ripening

Clinical Trial With Two Branches to Study the Effect of Semi-permanent Acupuncture at Specific Acupuncture Points on Reducing the Number of Inductions During Labor in Women at Low or Moderate Risk

NCT06357962•Consorci Sanitari de l'Alt Penedès i Garraf

View on ClinicalTrials.gov

Summary

Cervical ripening is a medical treatment that can cause physical or emotional discomfort in pregnant women and is not without risks. This is a pilot study to assess feasibility and calculate the number of participants necessary for a complete clinical trial. The aim is to evaluate whether acupuncture can reduce the need for treatment (cervical ripening) in pregnant women at low or intermediate risk. Participants will be divided into two groups: one group will receive acupuncture, and the other will receive a simulated treatment of acupuncture.

Eligibility

Age

0 - 40 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Anticipated delivery at the study center.
•Ability to collaborate in necessary evaluations.
•Legal capacity to provide informed consent.
•Signature of the informed consent for inclusion in the study, by oneself.

Exclusion Criteria

•Pregnancy with high or very high risk as described by the Pregnancy and Childbirth Monitoring Protocols of the Department of Health of Catalonia
•History of cesarean delivery.
•Language barrier preventing collaboration in study procedures.
•Cognitive or affective pathology limiting the ability to collaborate with study procedures.
•Participation in another clinical trial involving an experimental intervention during the period of this trial and/or establishing a visit frequency incompatible with this trial.

Locations (1)

Consorci Sanitari Alt Penedes i Garraf

Vilafranca del Penedès, Barcelona, Spain

Key Dates

Start Date

May 22, 2024

Primary Completion Date

March 16, 2025

Completion Date

April 19, 2025

Last Updated

December 1, 2025

Enrollment

ACTUAL participants

Conditions

Pregnancy Complications

Interventions

Semi-permanent acupuncture

OTHER

Sham of semi-permanent acupuncture

OTHER

Boston Birth Cohort Study

NCT03228875

Maternal HealthChild Health+2 more

View study

RECRUITINGPHASE2

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

NCT06237920

Urologic NeoplasmsUrogenital Neoplasms+9 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 1, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Semi-permanent Acupuncture Effect on Cervical Ripening

Inclusion Criteria

Exclusion Criteria

Boston Birth Cohort Study

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

Food Provision in Prenatal Care

Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome

Human Genes and Microbiota in Early Life